Published Date:2024-09-15 Original Link:https://www.onenessbio.com/en/news_detail319_1.htm No 1 Date of announcement 2024/09/15 Time of announcement 20:15:58 Subject National Health Security Administration of China has not included Fespixon Cream in this year NRDL adjustment negotiation after the expert review. To which item it meets paragraph 53 Date of events 2024/09/14 Statement Date of occurrence of the event: 2024/09/14...Read More

Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail317_1.htm No 1 Date of announcement 2024/09/08 Time of announcement 17:16:12 Subject SNS812 Phase 2 study demonstrated statistical significance in treating COVID-19 based on its safety, precision and broad-spectrum efficacy. To which item it meets paragraph 10 Date of events 2024/09/06 Statement Date of occurrence of the event: 2024/09/06 New drug name...Read More

Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail318_1.htm No 2 Date of announcement 2024/09/08 Time of announcement 18:18:59 Subject Oneness & Microbio (Shanghai) host an international press conference to present the pan-COVID new drug, SNS812 Phase 2 clinical trial results and future prospects To which item it meets paragraph 53 Date of events 2024/09/08 Statement Date of occurrence of...Read More

Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail316_1.htm No 2 Date of announcement 2024/09/05 Time of announcement 17:58:20 Subject The post hoc analysis of the global novel drug, Fespixon (ON101), on hard-to-heal diabetic foot ulcers has been published in Advances in Wound Care To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of...Read More

Published Date:2024-09-05 Original Link:https://www.onenessbio.com/en/news_detail315_1.htm No 1 Date of announcement 2024/09/05 Time of announcement 15:30:21 Subject The Company’s security trading have reached threshold of mandatory disclosure of financial information per TPEx requirements To which item it meets paragraph 53 Date of events 2024/09/05 Statement Date of occurrence of the event:2024/09/05 Cause of occurrence:Proceeded according to the...Read More

Published Date:2024-08-27 Original Link:https://www.onenessbio.com/en/news_detail314_2.htm No 1 Date of announcement 2024/08/27 Time of announcement 17:13:16 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/08/27 Statement Date of occurrence of the event: 2024/08/27...Read More

Published Date:2024-08-15 Original Link:https://www.onenessbio.com/en/news_detail313_2.htm No 1 Date of announcement 2024/08/15 Time of announcement 15:50:03 Subject Oneness Biotech Co., Ltd. receives a Philippine patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2024/08/15 Statement Date of occurrence of the event: 2024/08/15...Read More

Published Date:2024-08-12 Original Link:https://www.onenessbio.com/en/news_detail312_2.htm No 3 Date of announcement 2024/08/12 Time of announcement 16:34:05 Subject Announcement of change to the financial officer, accounting officer, acting spokesperson and corporate governance officer of the company. To which item it meets paragraph 8 Date of events 2024/08/12 Statement Type of personnel changed (please enter: spokesperson, acting spokesperson, important...Read More

Published Date:2024-08-12 Original Link:https://www.onenessbio.com/en/news_detail311_2.htm No 2 Date of announcement 2024/08/12 Time of announcement 16:29:17 Subject Oneness announces the resolution of the Board of Directors on the Record Date of Capital Increase for the issuance of Restricted Employee Shares in 2023. To which item it meets paragraph 53 Date of events 2024/08/12 Statement Date of occurrence...Read More

Published Date:2024-08-12 Original Link:https://www.onenessbio.com/en/news_detail310_2.htm No 1 Date of announcement 2024/08/12 Time of announcement 16:24:34 Subject The Company’s 2024Q2 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2024/08/12 Statement Date of the board of directors submitted or approved: 2024/08/12 Date of the audit...Read More